Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
US7838042 | AVION PHARMS | Hypoallergenic metal amino acid chelates and metal amino acid chelate-containing compositions |
Jun, 2027
(4 years from now) |
Drugs and Companies using ETHINYL ESTRADIOL; LEVONORGESTREL ingredient
Market Authorisation Date: 09 January, 2018
Treatment: Administration of ferrous bisglycinate tablets
Dosage: TABLET;ORAL
2
United States
1
Germany
1
European Union
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US11439613 | AVION PHARMS | Levodopa fractionated dose composition and use |
Mar, 2039
(15 years from now) | |
US11033521 | AVION PHARMS | Levodopa fractionated dose composition and use |
Mar, 2039
(15 years from now) |
Drugs and Companies using CARBIDOPA; LEVODOPA ingredient
Market Authorisation Date: 12 November, 2021
Treatment: Treatment of parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication; Treatment of parkinson's disease;...
Dosage: TABLET;ORAL
4
United States
2
Japan
1
China
1
Brazil
1
Canada
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic